Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children

Hans M.L. Spiegel, Elizabeth DeFalcon, Graham S. Ogg, Marie Larsson, Tom J. Beadle, Peter Tao, Andrew J. McMichael, Nina Bhardwaj, Chris O'Callaghan, William I. Cox, Keith Krasinski, Henry Pollack, William Borkowsky, Douglas F. Nixon

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

Combination antiretroviral therapy has had a major role in reducing human immunodeficiency virus type 1 (HIV-1) plasma viral loads in HIV-1- infected adults but a variable effect in infants, in whom complete viral suppression appears to be less readily achieved. In adults, after the reduction in plasma viremia, there is a decrease in the numbers of circulating cytotoxic T cell (CTL) effectors and precursors in the majority of patients. This longitudinal study assessed the effect of combination drug therapy on the frequency of HIV-1-specific CTL responses in 8 HIV-1-infected children. Following treatment, the frequency of HIV-1-specific CTL responses initially increased, especially in children with incomplete viral suppression but with increasing CD4+ cell counts. In children with complete viral suppression, the frequency of HIV-1-specific CTL responses decreased, suggesting that viral replication is required to maintain CTL responses in the systemic circulation.

Original languageEnglish
Pages (from-to)359-368
Number of pages10
JournalJournal of Infectious Diseases
Volume180
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Dive into the research topics of 'Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children'. Together they form a unique fingerprint.

Cite this